https://sr59230aantagonist.com..../assessment-associat
This review had been carried out according to the PRISMA guidelines additionally the protocol ended up being registered with PROSPERO on sixteenth April 2021 (ID no. CRD42021249443). Literature lookups were carried out making use of PsycINFO and Web of Science in March and November 2021, for studies reporting on DUR in CHR-P populations, pertaining to transition to psychosis or symptomatic, practical, or intellectual outcomes. The principal outcome had been change to psychosi
Like
Comment
Share
